A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
Gefitinib Combined With Thalidomide to Treat NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Rollover Protocol of Dacomitinib For Patients In Japan
- Status
- COMPLETED
- Phase
- PHASE2
Afatinib in NSCLC With HER2 Mutation
- Status
- COMPLETED
- Phase
- PHASE2
Novel Approach to Radiotherapy in Locally Advanced Lung Cancer Concomitant Navelbine®
- Status
- RECRUITING
- Phase
- NA
Induction Therapy With Intercalated Tyrosine Kinase Inhibitor (TKI) and Chemotherapy in NSCLC With Activating Epidermal Growth Factor Receptor (EGFR) Mutation in Stages II-IIIB
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
PET Response During Chemoradiation of Lung Cancer
- Status
- COMPLETED
- Phase
- NA
LUMINIST: LUng Cancer Molecular Insights Non Interventional Study
- Status
- COMPLETED
- Phase
- N/A
Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Expression and Sequence of Calcium Channels in Non-small Cell Lung Carcinoma (NSCLC)
- Status
- UNKNOWN
- Phase
- N/A
A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Paclitaxel-trastuzumab in EGFR-mutated NSCLC Patients
- Status
- UNKNOWN
- Phase
- PHASE2
EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel Plus Bevacizumab for Elderly Patients With Stage IV NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I Study of the Combination of Afatinib and Ruxolitinib in Patients With Treatment-refractory Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Erlotinib 100mg or 150mg in Treating EGFR Mutated NSCLC
- Status
- UNKNOWN
- Phase
- PHASE3
Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-up
- Status
- TERMINATED
- Phase
- N/A